PressSeptember 9, 2021 Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104
PressSeptember 8, 2021 Journey Colab secures $12M Series A funding for Phase 1 trial of Mescaline HCl, JOUR-001, for treatment of Alcohol Use Disorder
PressSeptember 7, 2021 Field Trip Health opens Europe’s first psychedelic therapy healthcare facility
PressSeptember 3, 2021 Filament Health Files 20th Patent Application Including Three International Pct Applications
PressSeptember 3, 2021 Field Trip Health Ltd. Announces Launch Of “Kap Co-Operative” Program, Enabling Independent Psychedelic Therapists To Practice At Its Field Trip Health Centers
PressSeptember 2, 2021 MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying Agitation Episodes
PressSeptember 1, 2021 Red Light Holland Successfully Completes Canada’s Largest Legal Sale and Import of Psilocybe Truffles into Canada Under a Health Canada Approved Psilocybin Import Permit
PressAugust 26, 2021 Awakn Life Sciences Initiates the First Ketamine Treatment Study for Gambling Addiction Led by Professor Celia Morgan
PressAugust 26, 2021 PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative Clinical Study
PressAugust 25, 2021 Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida
PressAugust 24, 2021 MindMed Announces Collaboration With Forian To Advance Development Of Personalized Psychiatry For Anxiety Disorders
PressAugust 24, 2021 Mindset Pharma Broadens its IP Portfolio by Filing U.S. Provisional Patent Extending its DMT and 5-MeO-DMT Inspired Psychedelic Drug Candidates
PressAugust 20, 2021 Silo Wellness Announces $3 Million U.S. Sales and Distribution Partnership for Marley One Line of Functional Mushrooms
PressAugust 19, 2021 Cybin Files Two Additional International Patent Applications in Support of the Company’s Research Phase Programs
PressAugust 17, 2021 Mydecine Innovations finishes 2Q with C$7M in cash after busy research period pinpoints four new lead drug candidates
PressAugust 17, 2021 Beckley Psytech completes oversubscribed $80m fundraise to develop portfolio of psychedelic medicine breakthroughs
